Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

18/11/2024

B2RLaw at IFG Flagship Fraud Conference | 20-21 November 2024 London

Join us for the International Fraud Group’s flagship conference in London! Edyta Zalewska and Jakub Przybyliński won’t miss this unique […]

MORE
12/11/2024

B2RLaw at ReBuild Ukraine: Construction & Energy 2024

We are attending the 4th International Exhibition & Conference ReBuild Ukraine Construction & Energy 2024 (13-14 November, EXPO XXI Warsaw). The event […]

MORE
25/10/2024

B2RLaw recommended in IFLR1000 ranking 2024

We are proud to announce that in this year’s edition of IFLR1000 ranking we have been recommended in 2 categories. Ranking by practice: […]

MORE
23/10/2024

European Commission VAT Expert Group Workshop summary, 14-15 October, Brussels

On 14 and 15 October, Jan Sarnowski, head of B2RLaw’s tax department, participated in a workshop of the EC VAT […]

MORE
21/10/2024

Agnieszka Hajos-Iwańska and Małgorzata Tomaka at AI<>BA Conference 2024

Join us at the AI<>BA conference at Muzeum Śląskie in Katowice – the sole conference that blends a variety of […]

MORE
13/10/2024

B2RLaw represents Poland at the European Commission workshop on the future of European VAT

On October 14th and 15th, Jan Sarnowski (Counsel, Tax Advisor, LL.M., Head of B2RLaw’s Tax Practice), will participate in the the […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close